Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
PAX5 modulates vascularization and contributes to neuroendocrine lineage transition during carcinoma progression.
Journal: The Journal of clinical investigation
Published: July 23, 2026
Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims data.
Journal: Frontiers in oncology
Published: June 19, 2025
Atypical Small Cell Lung Cancer: A New Malignancy Characterized by Chromothripsis, Carcinoid Tumors, and Wild-type RB1 and TP53.
Journal: Cancer discovery
Published: November 14, 2024
Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: November 01, 2024
KSR1 Mediates Small Cell Lung Carcinoma Tumor Initiation and Cisplatin Resistance.
Journal: Molecular cancer research : MCR
Published: July 08, 2024
Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report.
Journal: International journal of radiation oncology, biology, physics
Published: March 12, 2024
KSR1 mediates small-cell lung carcinoma tumor initiation and cisplatin resistance.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors.
Journal: Science advances
Published: January 19, 2024
Jumonji histone demethylases are therapeutic targets in small cell lung cancer.
Journal: Oncogene
Published: January 10, 2024
Proteomics: A new dimension to decode small cell lung cancer.
Journal: Cell
Published: November 14, 2023
Intrinsic electrical activity drives small-cell lung cancer progression.
Journal: Nature
Published: October 25, 2023
Last Updated: 09/26/2026